Page 107 - 南京医科大学自然版
P. 107

第44卷第5期               李盈盈,冯黎黎,韩 峰. 胶质母细胞瘤对替莫唑胺耐药机制的研究进展[J].
                  2024年5月                     南京医科大学学报(自然科学版),2024,44(5):688-697                        ·695 ·


                    paired primary and recurrent glioblastomas[J]. Int J Can⁃  [28]TOMAR V S,PATIL V,SOMASUNDARAM K. Temozolo⁃
                    cer,2011,129(3):659-670                            mide induces activation of Wnt/β⁃catenin signaling in gli⁃
               [16]ZHANG T X,CHAI J,CHI L Y. Induction of XLF and      oma cells via PI3K/Akt pathway:implications in glioma
                    53BP1 expression is associated with temozolomide resis⁃  therapy[J]. Cell Biol Toxicol,2020,36(3):273-278
                    tance in glioblastoma cells[J]. Onco Targets Ther,2019,  [29]YUN E J,KIM S,HSIEH J T,et al. Wnt/β⁃catenin signal⁃
                    12:10139-10151                                     ing pathway induces autophagy⁃mediated temozolomide⁃
               [17]KANG Y J,BALTER B,CSIZMADIA E,et al. Contribu⁃      resistance in human glioblastoma[J]. Cell Death Dis,
                    tion of classical end⁃joining to PTEN inactivation in p53⁃  2020,11(9):771
                    mediated glioblastoma formation and drug ⁃ resistant sur⁃  [30]LIU T,HU J,HAN B,et al. A positive feedback loop
                    vival[J]. Nat Commun,2017,8:14013                  of lncRNA⁃RMRP/ZNRF3 axis and Wnt/β⁃catenin signal⁃
               [18]YANG B,FU X Q,HAO J L,et al. PAXX participates in   ing regulates the progression and temozolomide resistance
                    base excision repair via interacting with pol β and contri⁃  in glioma[J]. Cell Death Dis,2021,12(11):952
                    butes to TMZ resistance in glioma cells[J]. J Mol Neuro⁃  [31]LIU B Y,ZHOU J,WANG C Y,et al. LncRNA SOX2OT
                    sci,2018,66(2):214-221                             promotes temozolomide resistance by elevating SOX2
               [19]DONG W,LI L L,TENG X P,et al. End processing factor  expression via ALKBH5 ⁃ mediated epigenetic regulation
                    APLF promotes NHEJ efficiency and contributes to TMZ⁃  in glioblastoma[J]. Cell Death Dis,2020,11(5):384
                    and ionizing radiation⁃resistance in glioblastoma cells[J].  [32]MENG X Q,ZHAO Y,HAN B,et al. Dual functionalized
                    Onco Targets Ther,2020,13:10593-10605              brain⁃targeting nanoinhibitors restrain temozolomide⁃re⁃
               [20]CHAI K M,WANG C Y,LIAW H J,et al. Downregulation    sistant glioma via attenuating EGFR and MET signaling
                    of BRCA1⁃BRCA2⁃containing complex subunit 3 sensitizes  pathways[J]. Nat Commun,2020,11(1):594
                    glioma cells to temozolomide[J]. Oncotarget,2014,5  [33]GOODWIN C R,RATH P,OYINLADE O,et al. Crizo⁃
                                                                                                       +
                   (21):10901-10915                                    tinib and erlotinib inhibits growth of c⁃Met /EGFRvⅢ  +
               [21]PATTIES I,KALLENDRUSCH S,BÖHME L,et al. The         primary human glioblastoma xenografts[J]. Clin Neurol
                    Chk1 inhibitor SAR⁃020106 sensitizes human glioblasto⁃  Neurosurg,2018,171:26-33
                    ma cells to irradiation,to temozolomide,and to decitabine  [34]HUANG W H,ZHONG Z,LUO C,et al. The miR⁃26a/
                    treatment[J]. J Exp Clin Cancer Res,2019,38(1):420  AP⁃2α/Nanog signaling axis mediates stem cell self⁃re⁃
               [22]LI H,CHEN L,LI J J,et al. MiR⁃519a enhances chemo⁃  newal and temozolomide resistance in glioma[J]. Ther⁃
                    sensitivity and promotes autophagy in glioblastoma by tar⁃  anostics,2019,9(19):5497-5516
                    geting STAT3/Bcl2 signaling pathway[J]. J Hematol On⁃  [35]ZHAO C G,YU H H,FAN X Q,et al. GSK3β palmi⁃
                    col,2018,11(1):70                                  toylation mediated by ZDHHC4 promotes tumorigenicity
               [23]GE X,PAN M H,WANG L,et al. Hypoxia⁃mediated mito⁃   of glioblastoma stem cells in temozolomide⁃resistant glio⁃
                    chondria apoptosis inhibition induces temozolomide treat⁃  blastoma through the EZH2⁃STAT3 axis[J]. Oncogene⁃
                    ment resistance through miR⁃ 26a/Bad/Bax axis[J]. Cell  sis,2022,11(1):28
                    Death Dis,2018,9(11):1128                    [36]CHIANG I T,LIU Y C,LIU H S,et al. Regorafenib reverses
               [24]CANCER GENOME ATLAS RESEARCH NETWORK.               temozolomide ⁃ induced CXCL12/CXCR4 signaling and
                    Comprehensive genomic characterization defines human  triggers apoptosis mechanism in glioblastoma[J]. Neuro⁃
                    glioblastoma genes and core pathways[J]. Nature,2008,  therapeutics,2022,19(2):616-634
                    455(7216):1061-1068                          [37]LI H Y,FENG Y H,LIN C L,et al. Mitochondrial mecha⁃
               [25]SINGH N,MINER A,HENNIS L,et al. Mechanisms of       nisms in temozolomide resistance:unraveling the complex
                    temozolomide resistance in glioblastoma ⁃ a comprehen⁃  interplay and therapeutic strategies in glioblastoma[J].
                    sive review[J]. Cancer Drug Resist,2021,4(1):17-43  Mitochondrion,2023,75:101836
               [26]XIE Y,ZHONG D W. AEG⁃1 is associated with hypoxia⁃  [38]GARCIA J H,JAIN S,AGHI M K. Metabolic drivers of in⁃
                    induced hepatocellular carcinoma chemoresistance via  vasion in glioblastoma[J]. Front Cell Dev Biol,2021,9:
                    regulating PI3K/AKT/HIF⁃ 1 alpha/MDR⁃ 1 pathway[J].  683276
                    EXCLI J,2016,15:745-757                      [39]TSAI Y T,LO W L,CHEN P Y,et al. Reprogramming of
               [27]PRASAD G,SOTTERO T,YANG X D,et al. Inhibition of    arachidonate metabolism confers temozolomide resistance
                    PI3K/mTOR pathways in glioblastoma and implications  to glioblastoma through enhancing mitochondrial activity
                    for combination therapy with temozolomide[J]. Neuro  in fatty acid oxidation[J]. J Biomed Sci,2022,29(1):21
                    Oncol,2011,13(4):384-392                     [40]CHENG S Y,CHEN N F,WEN Z H,et al. Glutathione S⁃
   102   103   104   105   106   107   108   109   110   111   112